{"id":1763224,"date":"2026-02-08T15:25:00","date_gmt":"2026-02-08T12:25:00","guid":{"rendered":"https:\/\/analyse.optim.biz\/?p=1763224"},"modified":"2026-02-08T15:25:00","modified_gmt":"2026-02-08T12:25:00","slug":"primul-pacient-oficial-care-va-beneficia-de-vaccinul-rusesc-anti-cancer-enteromix-daca-va-fi-o-reusita-atunci-big-pharma-occidentului-se-va-prabusi-cu-intreaga-industrie","status":"publish","type":"post","link":"https:\/\/analyse.optim.biz\/?p=1763224","title":{"rendered":"Primul pacient oficial care va beneficia de vaccinul rusesc anti-cancer ENTEROMIX. Daca va fi o reusit\u0103 atunci Big Pharma occidentului se va pr\u0103bu\u0219i cu intreaga industrie"},"content":{"rendered":"<p>[analyse_image type=&#8221;featured&#8221; src=&#8221;https:\/\/radiogoldfm.ro\/wp-content\/uploads\/2026\/02\/primul-pacient-oficial-care-va-beneficia-de-vaccinul-rusesc-anti-cancer-enteromix-daca-va-fi-o-reusit-atunci-big-pharma-occidentului-se-va-pr-bu-i-c-main.png&#8221;]<\/p>\n<div class=\"qt-the-content\">\n<p>ENTEROMIX este cea mai teribil\u0103 lovitur\u0103 pe care Rusia o poate da Occidentului. Dac\u0103 vaccinul anticancer va trece testele finale \u0219i va ajunge s\u0103 fie distribuit gratuit popula\u021biei, va pr\u0103bu\u0219i afacerea de aproape un trilion de euro, cat este estimat\u0103, anual, la nivelul european si nord american, cifra de afaceri in domeniul oncologiei.<\/p>\n<p>Primele etape ale testelor clinice au oferit rezultate absolut remarcabile, \u00eenregistr\u00e2nd o rat\u0103 de succes de sut\u0103 la sut\u0103. Aceast\u0103 descoperire reprezint\u0103 o raz\u0103 de speran\u021b\u0103 pentru milioane de oameni \u0219i ar putea redefini standardele tratamentelor oncologice la nivel global. Cercet\u0103torii continu\u0103 s\u0103 monitorizeze evolu\u021bia acestui tratament inovator care promite s\u0103 salveze nenum\u0103rate vie\u021bi \u00een viitorul apropiat.<\/p>\n<p>Jovana Aleksic, o s\u00e2rboaic\u0103 suferind de melanom cu metastaze multiple, este prima femeie din lume care va beneficia de vaccinul rusesc anticancer ENTEROMIX. Cu aceast\u0103 ocazie au fost dezv\u0103luite detalii ale tratamentului. Astfel, \u00een prima faz\u0103 se transmit mostre de \u021besut pe baza c\u0103rora este produs vaccinul (e vorba de un tratament personalizat). Produc\u021bia sa dureaz\u0103 dureaz\u0103 cam dou\u0103 s\u0103pt\u0103m\u00e2ni, iar fiecare pacient are nevoie de zece doze, administrate la fiecare dou\u0103 s\u0103pt\u0103m\u00e2ni.<\/p>\n<p>Partea interesant\u0103 este c\u0103 dup\u0103 a doua sau a treia doz\u0103 se poate stabili dac\u0103 tratamentul func\u021bioneaz\u0103 sau nu. \u00cens\u0103 rata de vindecare, \u00een conformitate cu produc\u0103torii, este uria\u0219\u0103. Desigur, rezultatele finale le vom vedea \u00een urma aplic\u0103rii acestor tratamente experimentale. Ceea ce garanteaz\u0103 \u00eens\u0103 produc\u0103torii este c\u0103 cei vindeca\u021bi nu se mai pot \u00eemboln\u0103vi de tipul de cancer pentru care au fost tratat deoarece dezvolt\u0103 imunitate la boal\u0103. Practic sistemul imunitar este \u00eenv\u0103\u021bat s\u0103 lupte natural \u00eempotriva acelui tip de tumoare.<\/p>\n<p><em><strong>surs\u0103: <a href=\"https:\/\/www.ziuanews.ro\/stiri\/primul-pacient-oficial-care-va-beneficia-de-vaccinul-rusesc-anti-cancer-enteromix-daca-va-fi-o-reusita-atunci-big-pharma-occidentului-se-va-prabu-i-cu-intreaga-industrie-1592563\">ziuanews.ro<\/a><\/strong><\/em><\/p>\n<div class=\"tagcloud qt-spacer-m\"><span class=\"qt-title\">Tagged as <\/span><a href=\"https:\/\/radiogoldfm.ro\/tag\/big-pharma\/\" rel=\"tag\">big pharma<\/a><a href=\"https:\/\/radiogoldfm.ro\/tag\/cancer\/\" rel=\"tag\">cancer<\/a><a href=\"https:\/\/radiogoldfm.ro\/tag\/enteromix\/\" rel=\"tag\">enteromix<\/a><a href=\"https:\/\/radiogoldfm.ro\/tag\/gold-fm\/\" rel=\"tag\">GOLD FM<\/a><a href=\"https:\/\/radiogoldfm.ro\/tag\/romania\/\" rel=\"tag\">romania<\/a><a href=\"https:\/\/radiogoldfm.ro\/tag\/rusia\/\" rel=\"tag\">rusia<\/a><a href=\"https:\/\/radiogoldfm.ro\/tag\/vaccin\/\" rel=\"tag\">vaccin<\/a><\/div>\n<div class=\"qt-post-author qt-card\">\n<div class=\"row\">\n<div class=\"qt-post-author-data col s10 m7 l7\">\n<h6>Profil<\/h6>\n<h4><a href=\"https:\/\/radiogoldfm.ro\/primul-pacient-oficial-care-va-beneficia-de-vaccinul-rusesc-anti-cancer-enteromix-daca-va-fi-o-reusita-atunci-big-pharma-occidentului-se-va-prabusi-cu-intreaga-industrie\/#author_page\">Gold FM Radio<\/a><\/h4>\n<\/div>\n<div class=\"qt-post-author-link col s12 m3 l4 \"><a href=\"https:\/\/radiogoldfm.ro\/author\/gold-fm\/\" class=\"qt-btn qt-btn-large qt-btn-primary aligncenter\">Arhiva postari<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n<p>[analyse_source url=&#8221;https:\/\/radiogoldfm.ro\/primul-pacient-oficial-care-va-beneficia-de-vaccinul-rusesc-anti-cancer-enteromix-daca-va-fi-o-reusita-atunci-big-pharma-occidentului-se-va-prabusi-cu-intreaga-industrie\/&#8221;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[analyse_image type=&#8221;featured&#8221; src=&#8221;https:\/\/radiogoldfm.ro\/wp-content\/uploads\/2026\/02\/primul-pacient-oficial-care-va-beneficia-de-vaccinul-rusesc-anti-cancer-enteromix-daca-va-fi-o-reusit-atunci-big-pharma-occidentului-se-va-pr-bu-i-c-main.png&#8221;] ENTEROMIX este cea mai teribil\u0103 lovitur\u0103 pe care Rusia o poate da Occidentului. Dac\u0103 vaccinul anticancer va trece testele finale \u0219i va ajunge s\u0103 fie distribuit gratuit popula\u021biei, va pr\u0103bu\u0219i afacerea de aproape un trilion de euro, cat este estimat\u0103, anual, la nivelul european si nord american, cifra de afaceri in domeniul [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[89],"tags":[226,96],"class_list":["post-1763224","post","type-post","status-publish","format-standard","hentry","category-romania","tag-crawlmanager","tag-radiogoldfm-ro"],"_links":{"self":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/1763224","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1763224"}],"version-history":[{"count":0,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=\/wp\/v2\/posts\/1763224\/revisions"}],"wp:attachment":[{"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1763224"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1763224"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/analyse.optim.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1763224"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}